Disc Medicine

US · IRON #2647 by market cap Listed 1970

61.18 -0.47 -0.76%

Live - 5344 symbols - heartbeat 103s ago · 2026-10-08 07:13

Pre-market 60.70 -0.78%

After-hours 61.12 -0.10%

Market cap: 2.35B
P/E (TTM): -9.28
P/B: 3.65
EPS: -6.01
Div yield: 0.00%
52W pos: 36%

Reader sentiment Are you bullish or bearish on IRON?

Anonymous reader poll. Unscientific, not investment advice.

About Disc Medicine

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Founded: 2017
CEO: Dr. John D. Quisel, J.D.,PhD
Employees: 155
Headquarters: Watertown, Massachusetts, United States of America
Fiscal year end: 12-31
Website: discmedicine.com

Company profile

Exchange: US
Symbol: IRON
Market-cap rank: #2647
Listing date: 1970-01-01
Market cap: 2.35B
Float cap: 2.01B
Shares out: 38.39M
Float shares: 32.91M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 07:13:37 · For reference only, not investment advice and not tailored to your situation.